...
首页> 外文期刊>Bosnian Journal of Basic Medical Sciences >Plasma Levels of Brain Natriuretic Peptides and Cardiac Troponin in Hemodialysis Patients
【24h】

Plasma Levels of Brain Natriuretic Peptides and Cardiac Troponin in Hemodialysis Patients

机译:血液透析患者血浆脑钠肽和心肌钙蛋白的水平

获取原文
           

摘要

Patients with End-Stage Renal Disease (ESRD) are at high risk of death as a result of the cardiovascular disease (CVD), which cannot be explained by the conventional risk factors only. Haemodialysis patients frequently have elevated serum concentrations of the cardiac troponins T, specifi c markers of myocardial injury. Plasma levels of brain natriuretic peptide (BNP) are elevated in fl uid volume overload and heart failure, and decreased during dialysis. Currently, LV hypertrophy and LV dysfunction are considered the strongest predictors of cardiovascular mortality in dialysis population, and the synthesis of cardiac natriuretic peptides is high in the presence of alterations in the left ventricular (LV) mass and function. Th e aim of this study was to investigate the factors associated with the increased serum levels of BNP and CTN in haemodialysis patients, and their impact on cardiovascular morbidity. In this cross-sectional study we included ?? patients with ESRD, without coronary symptoms, who were subjected to regular dialysis treatment three times a week for the duration of four hours. Heart failure was defi ned as an ejection fraction (EF) of < ???, and dyspnoea associated with either elevated jugular pressure or interstitial oedema evidenced in chest X-ray. All patients were in sinus rhythm at the time of the study. Twenty-fi ve patients were on erythropoietin treatment. Blood samples were taken before and after the dialysis session. Our study included ?? patients (?? males, ?? females). Th e average age was ??,? years (total range ??-??) divided into two groups: euvolemic and hypervolemic. Th e average dialysis time was ??,?±??,?? months. All haemodialysis patients had excessively high levels of BNP ????,??±????,?? ng/cm?. Plasma cTnT was found to be increased in ??,?? of patients. Patients with hypervolemia had signifi cantly higher cTnT levels (?,????±?,????), as compared to the euvolemic patients ?,????±?,???? p
机译:终末期肾病(ESRD)患者由于心血管疾病(CVD)处于高死亡风险,这不能仅由常规危险因素来解释。血液透析患者经常会升高心肌肌钙蛋白T的血清浓度,这是心肌损伤的特定标志。血浆容量过多和心力衰竭时血浆脑钠肽(BNP)水平升高,而在透析期间降低。当前,左心室肥大和左心功能不全被认为是透析人群中心血管死亡的最强预测因子,并且在左心室(LV)质量和功能发生变化的情况下,心脏利钠肽的合成很高。这项研究的目的是调查与血液透析患者血清BNP和CTN水平升高相关的因素及其对心血管疾病的影响。在此横断面研究中,我们包括了??没有冠状动脉症状的ESRD患者,每周接受3次常规透析治疗,持续4个小时。心力衰竭定义为射血分数(EF)≤???,并且在X线胸片中证实呼吸困难与颈静脉压力升高或间质性水肿有关。在研究时所有患者的窦性心律。 25名患者正在接受促红细胞生成素治疗。在透析之前和之后采集血样。我们的研究包括??患者(男性,女性)。平均年龄是??,?年(总范围??-??)分为两组:容量异常和高容量血症。平均透析时间为Δε,Δ±Δε,Δε。个月。所有血液透析患者的BNP都过高。 ng / cm?。发现血浆cTnT在??,??中增加。的患者。高血脂症患者的cTnT水平显着高于正常人(c),血友病患者的cTnT水平(?,????±?,????) p <?,??。升高的cTnT与BNP水平显着相关(p <?,??),而平均透析后BNP却没有显着降低(??? ,,±±??? ,,?; R =?,???; p-ns。)与透析前BNP(????,??±????,??; R = ???; p <?,??)相比。与透析后cTnT相比,透析前cTnT(α,β-α,α-β)低(平均α,β-β)。与高血容量患者的BMI,+/-±、、 (p-n.s。)。 BNP的增加与年龄(R-β,??? p-ns。)和透析时间(R-β,???)没有关系。血液透析期间血细胞比容水平显着升高(Δε,ε; p <ε,ε)。与正常心室功能正常的患者相比,具有更高BNP和cTnT的患者左心室质量指数明显更高。我们的研究表明??,??无症状血液透析患者的cTnT升高,而所有患者的BNP升高。测量脑钠素的血浆浓度可能对识别患有LVH的透析患者有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号